EU regulator wants more data on malaria drug's use for COVID-19

Healthcare professionals should closely monitor COVID-19 patients receiving malaria drug hydroxychloroquine for serious side effects, the European health regulator said on Friday, stressing the need for in-depth clinical data on benefits and risks.